Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
- PMID: 10471631
- DOI: 10.1164/ajrccm.160.3.9812110
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
Abstract
The mechanisms associated with the development of severe, corticosteroid (CS)-dependent asthma are poorly understood, but likely heterogenous. It was hypothesized that severe asthma could be divided pathologically into two inflammatory groups based on the presence or absence of eosinophils, and that the inflammatory subtype would be associated with distinct structural, physiologic, and clinical characteristics. Thirty-four severe, refractory CS-dependent asthmatics were evaluated with endobronchial biopsy, pulmonary function, allergy testing, and clinical history. Milder asthmatic and normal control subjects were also evaluated. Tissue cell types and subbasement membrane (SBM) thickness were evaluated immunohistochemically. Fourteen severe asthmatics [eosinophil (-)] had nearly absent eosinophils (< 2 SD from the normal mean). The remaining 20 severe asthmatics were categorized as eosinophil (+). Eosinophil (+) severe asthmatics had associated increases (p < 0.05) in lymphocytes (CD3+, CD4+, CD8+), mast cells, and macrophages. Neutrophils were increased in severe asthmatics and not different between the groups. The SBM was significantly thicker in eosinophil (+) severe asthmatics than eosinophil (-) severe asthmatics and correlated with eosinophil numbers (r = 0.50). Despite the absence of eosinophils and the thinner SBM, the FEV(1) was marginally lower in eosinophil (-) asthmatics (p = 0.05) with no difference in bronchodilator response. The eosinophil (+) group (with a thicker SBM) had more intubations than the eosinophil (-) group (p = 0.0004). Interestingly, this group also had a decreased FVC/slow vital capacity (SVC). These results suggest that two distinct pathologic, physiologic, and clinical subtypes of severe asthma exist, with implications for further research and treatment.
Similar articles
-
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease.Am J Respir Crit Care Med. 1998 Dec;158(6):1936-44. doi: 10.1164/ajrccm.158.6.9712073. Am J Respir Crit Care Med. 1998. PMID: 9847289
-
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):737-43. doi: 10.1164/ajrccm.156.3.9610046. Am J Respir Crit Care Med. 1997. PMID: 9309987
-
Eosinophilic inflammation in asthma.N Engl J Med. 1990 Oct 11;323(15):1033-9. doi: 10.1056/NEJM199010113231505. N Engl J Med. 1990. PMID: 2215562
-
Pathology of asthma.Allergy Proc. 1994 Nov-Dec;15(6):323-8. doi: 10.2500/108854194778816436. Allergy Proc. 1994. PMID: 7721082 Review.
-
Inflammatory mechanisms in childhood asthma.Clin Exp Allergy. 1998 Nov;28 Suppl 5:71-5; discussion 90-1. doi: 10.1046/j.1365-2222.1998.028s5071.x. Clin Exp Allergy. 1998. PMID: 9988450 Review.
Cited by
-
Benefits of Airway Androgen Receptor Expression in Human Asthma.Am J Respir Crit Care Med. 2021 Aug 1;204(3):285-293. doi: 10.1164/rccm.202009-3720OC. Am J Respir Crit Care Med. 2021. PMID: 33779531 Free PMC article.
-
Management of the patient with eosinophilic asthma: a new era begins.ERJ Open Res. 2015 Sep 23;1(1):00024-2015. doi: 10.1183/23120541.00024-2015. eCollection 2015 May. ERJ Open Res. 2015. PMID: 27730141 Free PMC article. Review.
-
Study of correlation between forced vital capacity and demand for healthcare services in severe asthmatics.Multidiscip Respir Med. 2015 Jul 22;10(1):22. doi: 10.1186/s40248-015-0020-5. eCollection 2015. Multidiscip Respir Med. 2015. PMID: 26199726 Free PMC article.
-
An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma.PLoS One. 2012;7(1):e28504. doi: 10.1371/journal.pone.0028504. Epub 2012 Jan 12. PLoS One. 2012. PMID: 22253691 Free PMC article.
-
Clinical usefulness of mepolizumab in severe eosinophilic asthma.Ther Clin Risk Manag. 2016 Jun 8;12:907-16. doi: 10.2147/TCRM.S86299. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27354806 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials